cbd
cbd · page 3
- Companies
Pharmaceutical Cannabis Steps Into the Spotlight as DanCann, Phytanix and Sandoz Unveil Major Moves
Welcome to Business of Cannabis’ new weekly strategic digest tracking the financial health, market moves, and corporate developments shaping the European cannabis sector.
- Uncategorized
Precision Over Potency: Personalised Cannabis Medicine is Coming of Age
One of the key differences between medical cannabis and other more traditional treatments is the highly personalised nature of how each patient is affected.
- Uncategorized
Full-Spectrum CBD Drug for Autism Spectrum Disorder Poised for Phase 2 Clinical Trials in the US
DeFloria, a joint venture between Charlotte’s Web Holdings and Ajna BioSciences, is advancing toward the start of its Phase 2 clinical trial for AJA001, a cannabinoid-based (FDA) botanical drug developed to treat behavioral symptoms associated with autism spectrum disorder (ASD).
- CBD Market
Italy’s Hemp Industry Dealt 2nd Major Blow as CBD Oil Classified as Narcotic
Italy’s hemp industry has been dealt another major blow this week as the Regional Administrative Court (TAR) rejected an appeal, rendering CBD oil a narcotic.
- CBD Market
UK’s FSA Softens Stance on 0% THC in CBD Products, as MHRA Draws Clear Line on CBD Medical Claims
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the Food Standards Agency (FSA) have both issued regulatory updates on CBD this week.
- Uncategorized
CBD Lawsuit Over Lost Job Gets Supreme Court’s Go-Ahead, Potentially Having Major Implications for Industry
The US Supreme Court voted in favour of a former truck driver’s right to use the Racketeer Influenced and Corrupt Organizations (RICO) Act to sue a company after he was sacked for testing positive for THC after taking a CBD supplement.
- CBD Market
Health Canada Proposes Making CBD Products Available Without Prescription
Canada’s health regulator has announced plans to establish a regulatory framework enabling CBD products to be sold over the counter without a prescription.
- CBD Market
Five More Companies Have Passed Novel Foods CBD Safety Assessment Since Start of the Year
The UK’s long and troubled CBD novel foods approval process seems to be gaining some momentum, as numerous major companies have announced their progression to the final risk assessment stage.
- Pharmaceutical
UK Start-up Targets Clinical Proof for Cannabis in Autism Spectrum Disorder
Kingdom Therapeutics, a UK-Irish biotech company, has passed a ‘major milestone’ in its ambitious journey towards launching clinical trials into cannabis and Autism Spectrum Disorder (ASD)
- Hemp Industry
Tide Turns in Italian Industry’s Favour as It Continues Its Fight for Survival
The Italian hemp industry has received unexpected support from the centre-right Forza Italia party, strengthening its position against an existential threat from the wider government.
- Uncategorized
Texas Senate Bill 3 Introduced: A Step Backward for the State’s Thriving Hemp Industry
Senator Charles Perry has officially filed Senate Bill 3 (SB 3), a sweeping piece of legislation that, while introducing some consumer protections, ultimately seeks to re-criminalize THC and nearly all other cannabinoids in Texas’ booming hemp market.
- CBD Market
Portugal Orders Removal of CBD Cosmetics as Crackdown Continues
As reported by CannaReporter Infarmed – the Portuguese National Authority for Medicines and Health Products (IP) has ordered the immediate withdrawal from the market of several cosmetic products containing cannabidiol (CBD), arguing that they do not comply with European legislation by using CBD from extracts, tinctures and resins of the cannabis plant.
